Effect of Ribavirin on Junin Virus Infection in Guinea Pigs

Zoonoses and Public Health

Volumn 59, Issue 4, 2012, Pages 278-285

  Salazar, M ^a   Yun, N E ^a   Poussard, A L ^a   Smith, J N ^a   Smith, J K ^a   Kolokoltsova, O A ^a   Patterson, M J ^a   Linde, J ^a   Paessler, S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Animal model; Antiviral therapy; Argentine haemorrhagic fever; Junin virus; Ribavirin

Indexed keywords

RIBAVIRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARGENTINE HEMORRHAGIC FEVER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GUINEA PIG; JUNIN VIRUS; LETHALITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS TRANSMISSION;

ANIMALS; ANTIVIRAL AGENTS; ARENAVIRIDAE INFECTIONS; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUINEA PIGS; JUNIN VIRUS; KAPLAN-MEIER ESTIMATE; POST-EXPOSURE PROPHYLAXIS; RIBAVIRIN; VERO CELLS;

ANIMALIA; CAVIA; JUNIN VIRUS;

EID: 84860365406     PISSN: 18631959     EISSN: 18632378     Source Type: Journal    
DOI: 10.1111/j.1863-2378.2011.01447.x     Document Type: Article

References (28)

1. Arribalzaga, R. A., 1955: New epidemic disease due to unidentified germ: nephrotoxic, leukopenic and enanthematous hyperthermia. Dia. Med. 27, 1204-1210.
2. Avila, M. M., S. R. Samoilovich, R. P. Laguens, M. S. Merani, and M. C. Weissenbacher, 1987: Protection of Junin virus-infected marmosets by passive administration of immune serum: association with late neurologic signs. J. Med. Virol. 21, 67-74.
3. Barrios, H. A., S. N. Rondinone, J. L. Blejer, O. A. Giovanniello, and N. R. Nota, 1982: Development of specific immune response in mice infected with Junin virus. Acta Virol. 26, 156-164.
4. Bowen, M. D., C. J. Peters, and S. T. Nichol, 1997: Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol. Phylogenet. Evol. 8, 301-316.
5. de Bracco, M. M., M. T. Rimoldi, P. M. Cossio, A. Rabinovich, J. I. Maiztegui, G. Carballal, and R. M. Arana, 1978: Argentine hemorrhagic fever. Alterations of the complement system and anti-Junin-virus humoral response. N. Engl. J. Med. 299, 216-221.
6. Campetella, O. E., N. V. Galassi, N. Sanjuan, and H. A. Barrios, 1988: Susceptible adult murine model for Junin virus. J. Med. Virol. 26, 443-451.
7. Carballal, G., J. R. Oubina, F. C. Molinas, C. Nagle, M. T. Vega, C. Videla, and B. Elsner, 1987: Intracerebral infection of Cebus apella with the XJ-Clone 3 strain of Junin virus. J. Med. Virol. 21, 257-268.
8. Centers for Disease Control, 2005. Arenavirus fact sheet. Centers for Disease Control, pp. 1-2.
9. De Clercq, E., 1993: Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact. Adv. Virus Res. 42. 1-55.
10. Enria, D. A., and J. G. Barrera Oro, 2002: Junin virus vaccines. Curr. Top. Microbiol. Immunol. 263, 239-261.
11. Enria, D. A., and J. I. Maiztegui, 1994: Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res. 23, 23-31.
12. Enria, D. A., A. M. Briggiler, and Z. Sanchez, 2008: Treatment of Argentine hemorrhagic fever. Antiviral Res. 78, 132-139.
13. Harrison, L. H., N. A. Halsey, K. T. McKee Jr, C. J. Peters, J. G. Barrera Oro, A. M. Briggiler, M. R. Feuillade, and J. I. Maiztegui, 1999: Clinical case definitions for Argentine hemorrhagic fever. Clin. Infect. Dis. 28, 1091-1094.
14. Iannacone, M., G. Sitia, M. Isogawa, J. K. Whitmire, P. Marchese, F. V. Chisari, Z. M. Ruggeri, and L. G. Guidotti, 2008: Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus. Proc. Natl. Acad. Sci. U S A 105, 629-634.
15. Kenyon, R. H., P. G. Canonico, D. E. Green, and C. J. Peters, 1986: Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (Junin virus) in guinea pigs. Antimicrob. Agents Chemother. 29, 521-523.
16. Kenyon, R. H., D. E. Green, J. I. Maiztegui, and C. J. Peters, 1988: Viral strain dependent differences in experimental Argentine hemorrhagic fever (Junin virus) infection of guinea pigs. Intervirology 29, 133-143.
17. Kilgore, P. E., T. G. Ksiazek, P. E. Rollin, J. N. Mills, M. R. Villagra, M. J. Montenegro, M. A. Costales, L. C. Paredes, and C. J. Peters, 1997: Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin. Infect. Dis. 24, 718-722.
18. Maiztegui, J. I., 1975: Clinical and epidemiological patterns of Argentine haemorrhagic fever. Bull. World Health Organ. 52, 567-575.
19. Maiztegui, J. I., N. J. Fernandez, and A. J. de Damilano, 1979: Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 2, 1216-1217.
20. Maiztegui, J., M. Feuillade, and A. Briggiler, 1986: Progressive extension of the endemic area and changing incidence of Argentine Hemorrhagic Fever. Med. Microbiol. Immunol. 175, 149-152.
21. Maiztegui, J. I., K. T. McKee Jr, J. G. Barrera Oro, L. H. Harrison, P. H. Gibbs, M. R. Feuillade, D. A. Enria, A. M. Briggiler, S. C. Levis, A. M. Ambrosio, N. A. Halsey, and C. J. Peters, 1998: Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. J. Infect. Dis. 177, 277-283.
22. McCormick, J. B., I. J. King, P. A. Webb, C. L. Scribner, R. B. Craven, K. M. Johnson, L. H. Elliott, and R. Belmont-Williams, 1986: Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314, 20-26.
23. McKee, K. T. Jr, B. G. Mahlandt, J. I. Maiztegui, G. A. Eddy, and C. J. Peters, 1985: Experimental Argentine hemorrhagic fever in rhesus macaques: viral strain-dependent clinical response. J. Infect. Dis. 152, 218-221.
24. Mills, J. N., B. A. Ellis, K. T. McKee Jr, T. G. Ksiazek, J. G. Oro, J. Maiztegui, G. E. Calderon, C. J. Peters, and J. E. Childs, 1991: Junin virus activity in rodents from endemic and nonendemic loci in central Argentina. Am. J. Trop. Med. Hyg. 44, 589-597.
25. Parodi, A. S., D. J. Greenway, H. R. Rugiero, M. Frigerio, J. M. De La Barrera, N. Mettler, F. Garzon, M. Boxaca, L. Guerrero, and N. Nota, 1958: Concerning the epidemic outbreak in Junin. Dia. Med. 30, 2300-2301.
26. Sidwell, R. W., J. H. Huffman, G. P. Khare, B. Allen, J. T. Witkowski, and K. Robins, 1972: Broad-spectrum antiviral activity of Virazole: 1-beta-d-ribofuranosyl- 1, 2, 4-triazole -3-carboxamide. Science 177, 705-706.
27. Smith, R. A., and K. William, 1980: Ribavirin, a Broad Spectrum Antiviral Agent.
28. Yun, N. E., N. S. Linde, N. Dziuba, M. A. Zacks, J. N. Smith, J. K. Smith, J. F. Aronson, O. V. Chumakova, H. M. Lander, C. J. Peters, and S. Paessler, 2008: Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs. Am. J. Trop. Med. Hyg. 79, 275-282.